Global 3-Fucosyllactose (3FL) 麻豆原创 Growth 2025-2031

Publication ID:

LPI06251574

Publication Date:

June 27, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Food Processing [2]

Food [3]

Food & Beverages [4]

Description:

The global 3-Fucosyllactose (3FL) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for 3-Fucosyllactose (3FL) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for 3-Fucosyllactose (3FL) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for 3-Fucosyllactose (3FL) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key 3-Fucosyllactose (3FL) players cover DSM, Elicityl, Friesland Foods, Abbott, Inbiose, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥�3-Fucosyllactose (3FL) Industry Forecast鈥� looks at past sales and reviews total world 3-Fucosyllactose (3FL) sales in 2024, providing a comprehensive analysis by region and market sector of projected 3-Fucosyllactose (3FL) sales for 2025 through 2031. With 3-Fucosyllactose (3FL) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 3-Fucosyllactose (3FL) industry.
This Insight Report provides a comprehensive analysis of the global 3-Fucosyllactose (3FL) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 3-Fucosyllactose (3FL) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global 3-Fucosyllactose (3FL) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 3-Fucosyllactose (3FL) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 3-Fucosyllactose (3FL).
This report presents a comprehensive overview, market shares, and growth opportunities of 3-Fucosyllactose (3FL) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Acidic
Neutral
Segmentation by Application:
Infant Formula Food
Food Supplements
Special Medical Purposes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
DSM
Elicityl
Friesland Foods
Abbott
Inbiose
Jennewein Biotechnologie GmbH (Chr. Hansen)
zuChem
Kirin Holdings Company
E-biochem
Peptech
Key Questions Addressed in this Report
What is the 10-year outlook for the global 3-Fucosyllactose (3FL) market?
What factors are driving 3-Fucosyllactose (3FL) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 3-Fucosyllactose (3FL) market opportunities vary by end market size?
How does 3-Fucosyllactose (3FL) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global 3-Fucosyllactose (3FL) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for 3-Fucosyllactose (3FL) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for 3-Fucosyllactose (3FL) by Country/Region, 2020, 2024 & 2031
2.2 3-Fucosyllactose (3FL) Segment by Type
2.2.1 Acidic
2.2.2 Neutral
2.3 3-Fucosyllactose (3FL) Sales by Type
2.3.1 Global 3-Fucosyllactose (3FL) Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global 3-Fucosyllactose (3FL) Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global 3-Fucosyllactose (3FL) Sale Price by Type (2020-2025)
2.4 3-Fucosyllactose (3FL) Segment by Application
2.4.1 Infant Formula Food
2.4.2 Food Supplements
2.4.3 Special Medical Purposes
2.5 3-Fucosyllactose (3FL) Sales by Application
2.5.1 Global 3-Fucosyllactose (3FL) Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global 3-Fucosyllactose (3FL) Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global 3-Fucosyllactose (3FL) Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global 3-Fucosyllactose (3FL) Breakdown Data by Company
3.1.1 Global 3-Fucosyllactose (3FL) Annual Sales by Company (2020-2025)
3.1.2 Global 3-Fucosyllactose (3FL) Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global 3-Fucosyllactose (3FL) Annual Revenue by Company (2020-2025)
3.2.1 Global 3-Fucosyllactose (3FL) Revenue by Company (2020-2025)
3.2.2 Global 3-Fucosyllactose (3FL) Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global 3-Fucosyllactose (3FL) Sale Price by Company
3.4 Key Manufacturers 3-Fucosyllactose (3FL) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 3-Fucosyllactose (3FL) Product Location Distribution
3.4.2 Players 3-Fucosyllactose (3FL) Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for 3-Fucosyllactose (3FL) by Geographic Region
4.1 World Historic 3-Fucosyllactose (3FL) 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global 3-Fucosyllactose (3FL) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global 3-Fucosyllactose (3FL) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic 3-Fucosyllactose (3FL) 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global 3-Fucosyllactose (3FL) Annual Sales by Country/Region (2020-2025)
4.2.2 Global 3-Fucosyllactose (3FL) Annual Revenue by Country/Region (2020-2025)
4.3 Americas 3-Fucosyllactose (3FL) Sales Growth
4.4 APAC 3-Fucosyllactose (3FL) Sales Growth
4.5 Europe 3-Fucosyllactose (3FL) Sales Growth
4.6 Middle East & Africa 3-Fucosyllactose (3FL) Sales Growth
5 Americas
5.1 Americas 3-Fucosyllactose (3FL) Sales by Country
5.1.1 Americas 3-Fucosyllactose (3FL) Sales by Country (2020-2025)
5.1.2 Americas 3-Fucosyllactose (3FL) Revenue by Country (2020-2025)
5.2 Americas 3-Fucosyllactose (3FL) Sales by Type (2020-2025)
5.3 Americas 3-Fucosyllactose (3FL) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 3-Fucosyllactose (3FL) Sales by Region
6.1.1 APAC 3-Fucosyllactose (3FL) Sales by Region (2020-2025)
6.1.2 APAC 3-Fucosyllactose (3FL) Revenue by Region (2020-2025)
6.2 APAC 3-Fucosyllactose (3FL) Sales by Type (2020-2025)
6.3 APAC 3-Fucosyllactose (3FL) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 3-Fucosyllactose (3FL) by Country
7.1.1 Europe 3-Fucosyllactose (3FL) Sales by Country (2020-2025)
7.1.2 Europe 3-Fucosyllactose (3FL) Revenue by Country (2020-2025)
7.2 Europe 3-Fucosyllactose (3FL) Sales by Type (2020-2025)
7.3 Europe 3-Fucosyllactose (3FL) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 3-Fucosyllactose (3FL) by Country
8.1.1 Middle East & Africa 3-Fucosyllactose (3FL) Sales by Country (2020-2025)
8.1.2 Middle East & Africa 3-Fucosyllactose (3FL) Revenue by Country (2020-2025)
8.2 Middle East & Africa 3-Fucosyllactose (3FL) Sales by Type (2020-2025)
8.3 Middle East & Africa 3-Fucosyllactose (3FL) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 3-Fucosyllactose (3FL)
10.3 Manufacturing Process Analysis of 3-Fucosyllactose (3FL)
10.4 Industry Chain Structure of 3-Fucosyllactose (3FL)
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 3-Fucosyllactose (3FL) Distributors
11.3 3-Fucosyllactose (3FL) Customer
12 World Forecast Review for 3-Fucosyllactose (3FL) by Geographic Region
12.1 Global 3-Fucosyllactose (3FL) 麻豆原创 Size Forecast by Region
12.1.1 Global 3-Fucosyllactose (3FL) Forecast by Region (2026-2031)
12.1.2 Global 3-Fucosyllactose (3FL) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global 3-Fucosyllactose (3FL) Forecast by Type (2026-2031)
12.7 Global 3-Fucosyllactose (3FL) Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 DSM
13.1.1 DSM Company Information
13.1.2 DSM 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.1.3 DSM 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 DSM Main Business Overview
13.1.5 DSM Latest Developments
13.2 Elicityl
13.2.1 Elicityl Company Information
13.2.2 Elicityl 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.2.3 Elicityl 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Elicityl Main Business Overview
13.2.5 Elicityl Latest Developments
13.3 Friesland Foods
13.3.1 Friesland Foods Company Information
13.3.2 Friesland Foods 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.3.3 Friesland Foods 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Friesland Foods Main Business Overview
13.3.5 Friesland Foods Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.4.3 Abbott 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 Inbiose
13.5.1 Inbiose Company Information
13.5.2 Inbiose 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.5.3 Inbiose 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Inbiose Main Business Overview
13.5.5 Inbiose Latest Developments
13.6 Jennewein Biotechnologie GmbH (Chr. Hansen)
13.6.1 Jennewein Biotechnologie GmbH (Chr. Hansen) Company Information
13.6.2 Jennewein Biotechnologie GmbH (Chr. Hansen) 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.6.3 Jennewein Biotechnologie GmbH (Chr. Hansen) 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Jennewein Biotechnologie GmbH (Chr. Hansen) Main Business Overview
13.6.5 Jennewein Biotechnologie GmbH (Chr. Hansen) Latest Developments
13.7 zuChem
13.7.1 zuChem Company Information
13.7.2 zuChem 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.7.3 zuChem 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 zuChem Main Business Overview
13.7.5 zuChem Latest Developments
13.8 Kirin Holdings Company
13.8.1 Kirin Holdings Company Company Information
13.8.2 Kirin Holdings Company 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.8.3 Kirin Holdings Company 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Kirin Holdings Company Main Business Overview
13.8.5 Kirin Holdings Company Latest Developments
13.9 E-biochem
13.9.1 E-biochem Company Information
13.9.2 E-biochem 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.9.3 E-biochem 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 E-biochem Main Business Overview
13.9.5 E-biochem Latest Developments
13.10 Peptech
13.10.1 Peptech Company Information
13.10.2 Peptech 3-Fucosyllactose (3FL) Product Portfolios and Specifications
13.10.3 Peptech 3-Fucosyllactose (3FL) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Peptech Main Business Overview
13.10.5 Peptech Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.